[go: up one dir, main page]

GB0226731D0 - Method for generating immunoglobulin genes - Google Patents

Method for generating immunoglobulin genes

Info

Publication number
GB0226731D0
GB0226731D0 GB0226731A GB0226731A GB0226731D0 GB 0226731 D0 GB0226731 D0 GB 0226731D0 GB 0226731 A GB0226731 A GB 0226731A GB 0226731 A GB0226731 A GB 0226731A GB 0226731 D0 GB0226731 D0 GB 0226731D0
Authority
GB
United Kingdom
Prior art keywords
immunoglobulin genes
generating immunoglobulin
generating
genes
immunoglobulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0226731A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GB0226731A priority Critical patent/GB0226731D0/en
Publication of GB0226731D0 publication Critical patent/GB0226731D0/en
Priority to PCT/GB2003/004964 priority patent/WO2004046189A2/en
Priority to JP2004570301A priority patent/JP2006521088A/en
Priority to AU2003282247A priority patent/AU2003282247A1/en
Priority to CA002506128A priority patent/CA2506128A1/en
Priority to AU2003283578A priority patent/AU2003283578A1/en
Priority to PCT/GB2003/004953 priority patent/WO2004046188A2/en
Priority to EP03773865A priority patent/EP1565495A2/en
Priority to US11/127,903 priority patent/US20050288492A1/en
Ceased legal-status Critical Current

Links

GB0226731A 2002-11-15 2002-11-15 Method for generating immunoglobulin genes Ceased GB0226731D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB0226731A GB0226731D0 (en) 2002-11-15 2002-11-15 Method for generating immunoglobulin genes
PCT/GB2003/004964 WO2004046189A2 (en) 2002-11-15 2003-11-14 Method for generating immunoglobulin genes
JP2004570301A JP2006521088A (en) 2002-11-15 2003-11-14 Anti-activated RAS antibody
AU2003282247A AU2003282247A1 (en) 2002-11-15 2003-11-14 Anti-activated ras antibodies
CA002506128A CA2506128A1 (en) 2002-11-15 2003-11-14 Anti-activated ras antibodies
AU2003283578A AU2003283578A1 (en) 2002-11-15 2003-11-14 Method for generating immunoglobulin genes
PCT/GB2003/004953 WO2004046188A2 (en) 2002-11-15 2003-11-14 Anti-activated ras antibodies
EP03773865A EP1565495A2 (en) 2002-11-15 2003-11-14 Anti-activated ras antibodies
US11/127,903 US20050288492A1 (en) 2002-11-15 2005-05-12 Anti-activated RAS antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0226731A GB0226731D0 (en) 2002-11-15 2002-11-15 Method for generating immunoglobulin genes

Publications (1)

Publication Number Publication Date
GB0226731D0 true GB0226731D0 (en) 2002-12-24

Family

ID=9947937

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0226731A Ceased GB0226731D0 (en) 2002-11-15 2002-11-15 Method for generating immunoglobulin genes

Country Status (3)

Country Link
AU (1) AU2003283578A1 (en)
GB (1) GB0226731D0 (en)
WO (1) WO2004046189A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2490280A1 (en) 2002-07-01 2004-01-08 Human Genome Sciences, Inc. Antibodies that specifically bind to reg iv
WO2004033485A2 (en) 2002-10-09 2004-04-22 The Trustees Of Boston University Nucleic acid supported protein complementation
US9879087B2 (en) 2014-11-12 2018-01-30 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
EP4183806A3 (en) 2014-11-12 2023-08-02 Seagen Inc. Glycan-interacting compounds and methods of use
IL258768B2 (en) 2015-11-12 2023-11-01 Siamab Therapeutics Inc Glycan-interacting compounds and methods of use
US11401330B2 (en) 2016-11-17 2022-08-02 Seagen Inc. Glycan-interacting compounds and methods of use
KR102653141B1 (en) 2017-03-03 2024-04-01 씨젠 인크. Glycan-interacting compounds and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB2344886B (en) * 1999-03-10 2000-11-01 Medical Res Council Selection of intracellular immunoglobulins

Also Published As

Publication number Publication date
AU2003283578A1 (en) 2004-06-15
WO2004046189A2 (en) 2004-06-03
AU2003283578A8 (en) 2004-06-15
WO2004046189A3 (en) 2004-09-16

Similar Documents

Publication Publication Date Title
GB0208104D0 (en) Method
GB0211975D0 (en) Method
HK1085592A1 (en) Method for generating pseudo-random sequence
AU2003258070A8 (en) Electrodionization method
EP1625829A4 (en) Ultrasonogram generation method
GB0214209D0 (en) Method
GB0215034D0 (en) Architecture generation method
AU2003283578A8 (en) Method for generating immunoglobulin genes
GB0213261D0 (en) Method
GB0205509D0 (en) Method
AU2003291631A8 (en) Method for regulating expression genes
GB0209296D0 (en) Method
AU2003253813A8 (en) Method for colpoplasty
EP1556396A4 (en) Method for producing 2-deoxy-l-ribose
EP1534827A4 (en) Method for generating monoclonal antibodies
GB0200865D0 (en) Method
GB0208383D0 (en) Method
GB0207266D0 (en) Method
AU2003262730A1 (en) Method for generating antibodies
GB0218351D0 (en) Generating apparatus
GB0205469D0 (en) Method
GB0207167D0 (en) Method
GB0208875D0 (en) Method
GB0208906D0 (en) Method
GB0209624D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)